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INTRODUCTION
There are three types of gynecological cancers that
require special attention for their primary preven-
tion, i.e. uterine cervical cancer, ovarian cancer, and
endometrial cancer. These three cancers constitute
the three most frequently encountered cancers in
the world in general, and in Indonesia in particular.
Primary preventive efforts required data obtained
from epidemiological studies on the factors contri-
buting to the onset of malignancy. Primary preven-
tion generally is not an invasive intervention, al-
though over the last decade there have been some
developments concerning malignancy and preven-
tive surgery. A great many women did not provide
special attention to the prevention of primary ma-
lignancy, such as avoiding risk factors, undergoing
periodic examinations for early detection of malig-
nancy. In addition, medical personnel tended to
overlook the efforts at primary prevention, and the
selection of and policies in administering therapy.
The selection of contraceptives should be tailored
to the policies of primary prevention, in addition to
serving their primary purposes. This will be of great
benefits to the high-risk patients suffering from ma-
lignancy. This paper aimed to raise the awareness
of physicians in participating in the efforts of pri-
mary prevention in gynecological cancers.
Cervical Cancer
There are a number of risk factors in cervical can-
cer, either the risks of the onset of cervical cancer
or the risks of aggravation and precipitation of the
incidence of cervical cancer or degeneration into
invasive cervical cancer.
Pendahuluan: Terdapat tiga jenis kanker yang banyak diderita oleh
wanita dalam bidang ginekologi, yaitu kanker serviks, kanker ovarium
dan kanker endometrium. Patofisiologi kanker serviks hampir dikenal
dengan baik, sedangkan patofisiologi kanker ovarium mulai terbuka, dan
patofisiologi kanker endometrium juga mulai diketahui. Dengan dasar
tersebut dilakukan penelitian terhadap faktor risiko timbulnya kanker gi-
nekologi. Pengenalan faktor risiko yang didapat dari penelitian
epidemiologi menjadi dasar untuk melakukan upaya pencegahan primer
kanker ginekologi. Pencegahan primer dilakukan dengan memberikan
nasihat dan terapi yang mempunyai pengaruh menurunkan risiko timbul-
nya kanker ginekologi.
Tujuan: Menyampaikan kebijakan pencegahan primer kanker gine-
kologi berdasarkan hasil penelitian epidemiologi.
Bahan dan cara kerja: Kajian pustaka.
Hasil: Kanker serviks risikonya dapat diturunkan dengan menghin-
dari pola pasangan ganda, menghindari merokok, mengkonsumsi ma-
kanan yang kaya vitamin C. Kanker ovarium risikonya dapat diturunkan
dengan memberi kontrasepsi oral, menyusui, sterilisasi ataupun histerek-
tomi. Kanker endometrium dapat diturunkan risikonya dengan memberi-
kan kontrasepsi oral kombinasi, menurunkan berat badan.
Kesimpulan: Dapat dilakukan upaya menurunkan risiko timbulnya
kanker ginekologi melalui pencegahan primer.
[Maj Obstet Ginekol Indones 2006; 30-4: 245-8]
Kata kunci: pencegahan primer, kanker ginekologi
Introduction: There are three types of cancer commonly suffered by
women in the field of gynecology, i.e. cervical cancer, ovarian cancer,
and endometrial cancer. Pathophysiology of cervical cancers is almost
well known, while pathophysiology of ovarian cancer has begun to un-
fold, and so has the pathophysiology of endometrial cancer. Based on
such understanding, studies were conducted of the risk factors of the oc-
currence of gynecological cancers. Identification of risk factors ob-
tained from epidemiological studies served as the foundation for under-
taking primary prevention of gynecological cancer. Primary prevention
could be performed by providing advice and therapy aimed at reducing
the risk for the incidence of gynecological cancers.
Objective: To present the policies in primary preventions of gyneco-
logical cancers based on the results of epidemiological studies.
Material and methods: Literature review.
Results: The risks of cervical cancer could be reduced by refraining
from multiple sexual partnership, smoking, and by consuming foods rich
in vitamin C. The risks of ovarian cancers could be reduced by provid-
ing oral contraceptives, breastfeeding, sterilization, or hysterectomy.
The risks of endometrial cancer could be reduced by providing com-
bined oral contraceptives, and reducing body weight.
Conclusions: Efforts could be made to reduce the risks of gyneco-
logical cancers through primary prevention.
[Indones J Obstet Gynecol 2006; 30-4: 245-8]
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It has been known that HPV (human papilloma
virus) is a vector that plays a major role in the
incidence of cervical cancer of the uterus, and this
virus is responsible for sexually transmitted di-
seases in the sense that the majority of transmis-
sions occur by way of sexual intercourse. There-
fore, the primary preventive initiative should be
aimed at avoiding multiple partnership for both
women and men. Pap smear examinations per-
formed to discover cases at the stage of pre-can-
cerous lesion constitute the efforts to provide early
detection and immediate treatment to prevent its
further degeneration into cervical cancer.1,2,3
N Smoking habit. It has been known that smoking
increases the risk of cervical cancer twice as
high, with odds ratio ranging from 1.8 to 10.1.
In addition, there is a trend of growing risks with
the increase of smoking dosage, i.e. the higher
the smoking dosage, the higher the risk for de-
veloping cervical cancer.4,5
N Dietary habit also plays a role in the risk for
developing cervical cancer of the uterus. Case-
control studies showed that diet of high vitamin
C was associated with lower risks for developing
cervical cancer, i.e. 31% lower with odds ratio
of 0.7% than those who had dietary habit with
low vitamin C. Thus, dietary habit with vitamin
C intake plays a part in preventing cervical ma-
lignancy. The efficacy of vitamin C in preventing
malignancy was also evident among smokers.
The risk of developing cervical cancer among
smokers with dietary intake of low vitamin C
will increase 2.2 times as high. (1.1 - 4.4).6,7
N The use of oral contraceptives, as shown by some
studies, proved to increase the risk of developing
cervical cancer by up to 60%, with odds ratio of
1.5 - 1.8, and the risk will increase in proportion
to the longer use of these contraceptives. In women
with HPV infection and using oral contraceptives
for five years, the risk of developing cervical can-
cer increased 1.3 times and 1.7 times for a use of
five to nine years. There is a strong correlation
between the incidence of cervical adenocarcinoma
and the use of oral contraceptives, since the use
of oral contraceptives will increase the risk for de-
veloping cervical adenocarcinoma in women with
HPV infection 6 - 12.6 times.8 Therefore, in the
group of high-risk women, it is advisable that
the administration of oral contraceptives be
avoided.9,10,11
N As shown by some studies, the use of diaphragm
contraceptives in women did not produce adverse
effects, or preventive effects, on the incidence of
cervical cancer of the uterus (odds ratio 0.2 -
1.2). Similarly, the use of condom as a contra-
ceptive method in these studies provided a vari-
ety of results, with odds ratio ranging between
0.2 and 0.9.11,12 On the other hand, these studies
showed that vaginal spermicide was efficacious
in providing preventive effects with odds ratio
of 0.1 - 0.7. It may be concluded then that the
use of spermicide will reduce the risks of cervi-
cal cancer of the uterus.11,12
Endometrial Cancer
Endometrial cancers are comprised of both hormo-
nal-dependent and nonhormonal-dependent endome-
trial cancers. However, epidemiological studies did
not divide the cases of endometrial cancers clini-
cally. A number of factors have been implicated as
the risk factors, such as obesity, hypertension, dia-
betes mellitus, and unovulated cycles. Estrogen fac-
tor or estrogen receptor factor was still considered
as the basis for the incidence of endometrial cancer,
with odds ratio of 0.1 - 0.6, and most of the studies
found odds ratio at 0.5.
N Normal body weight is a very significant indi-
cation of primary prevention of endometrial can-
cer, since obesity obviously increases the risk for
developing endometrial cancer with odds ratio of
1.0-20.3. Thus, the effort to reduce body weight
in high-risk women is the most appropriate op-
tion.13
N  Oral contraceptives. The use of combined oral
contraceptives proved to provide protective ef-
fects for patients against the possible develop-
ment of endometrial cancer. Protection will par-
ticularly occur with the use of oral contracep-
tives for one year.14,15,16,17
Ovarian Cancer
Ovarian cancer has been widely known to carry
risks or to belong to the series of family cancers.
The risks for developing ovarian cancer and breast
cancer are noted in the families possessing BRCA
1 or BRCA 2. Inclusion cyst, which was considered
the precursor of ovarian cancer resulting from ovu-
lation trauma, is regarded as a risk factor. The trig-
gering of ovulation will increase the risk for deve-
loping inclusion cyst or ovarian cyst, or ovarian
cancer.
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N Prevention of ovulation is an important step in
primary prevention, because by doing so the pos-
sible occurrence of inclusion cyst is averted,
which may degenerate into ovarian tumor and
ovarian cancer. Oral contraceptives that are effi-
cacious in preventing ovulation have proved to
be effective in reducing the risks for the occur-
rence of ovarian cancer. Almost all epidemio-
logical studies showed the benefits of oral con-
traceptives in preventing the occurrence of ova-
rian cancer. With relative risk of 0.3 - 0.6 and
the outcome of 0.6 in meta-analysis, the benefits
of oral contraceptives as a means of preventing
primary ovarian cancer have been proven.18,19
N Breastfeeding has been shown to reduce the risk
for the occurrence of ovarian cancer with odds
ratio of 0.7. The effects of breastfeeding in low-
ering the risks of ovarian cancer may be due to
the fact that the ovulated menstrual cycles are
disrupted.
N Sterilization intervention. In epidemiological stu-
dies, sterilization interventions have been showed
to be effective in reducing the risk of ovarian ma-
lignancy with a relative risk of 0.3. Sterilization
intervention is associated with the disconnection
of relationship between ovaries and the outside
world through fallopian tube, such that carcinogen
substances that may enter through the vagina and
tube will be averted by sterilization intervention.
This result did not differ from that achieved by
women through hysterectomy. It was reported that
in women who underwent hysterectomy the risk
for developing ovarian cancer was reduced.20
With a reference to the data obtained from epi-
demiological studies, the efforts at primary preven-
tion can be made by taking into account the risk
factors of patients. The selection of contraceptive
methods, and changes of dietary habits to support
the preventive effects should made carefully. The
ideas which are based on such data will definitely
change the mindset of physicians in administering
therapy or providing advice during consultation.
Such efforts should be made in a case-by-case man-
ner by taking into account risk factors.
CONCLUSIONS
The risks for the occurrence of cervical cancers
could be reduced by avoiding the lifestyle of mul-
tiple partnerships, smoking, and by consuming vi-
tamin C-rich foods. Contraceptive pills could in-
crease the risk for developing cervical cancer of the
uterus. The risks for developing ovarian cancer
could be reduced by administering oral contracep-
tives, breastfeeding, and sterilization or hysterec-
tomy. Meanwhile, the risks for the occurrence of
endometrial cancers could be reduced by providing
combined oral contraceptives and by reducing body
weight appropriately.
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